Singapore markets closed
Straits Times Index
3,110.73 +36.47 (+1.19%) Nikkei
32,307.86 -550.45 (-1.68%) Hang Seng
16,334.37 -11.52 (-0.07%) FTSE 100
7,574.66 +60.94 (+0.81%) Bitcoin USD
43,946.80 +141.47 (+0.32%) CMC Crypto 200
907.35 +10.64 (+1.19%)
Lyell Immunopharma, Inc. (LYEL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:40AM EST. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 483.71M |
| Enterprise value | -33.14M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | 9.90 |
| Price/book (mrq) | 0.69 |
| Enterprise value/revenue | -0.68 |
| Enterprise value/EBITDA | 0.18 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.95 |
| 52-week change 3 | -44.65% |
| S&P500 52-week change 3 | 16.55% |
| 52-week high 3 | 3.9700 |
| 52-week low 3 | 1.3200 |
| 50-day moving average 3 | 1.7243 |
| 200-day moving average 3 | 2.3149 |
Share statistics
| Avg vol (3-month) 3 | 928.73k |
| Avg vol (10-day) 3 | 992.08k |
| Shares outstanding 5 | 251.87M |
| Implied shares outstanding 6 | 251.87M |
| Float 8 | 161.13M |
| % held by insiders 1 | 15.72% |
| % held by institutions 1 | 68.50% |
| Shares short (14 Nov 2023) 4 | 17.74M |
| Short ratio (14 Nov 2023) 4 | 17.4 |
| Short % of float (14 Nov 2023) 4 | 10.07% |
| Short % of shares outstanding (14 Nov 2023) 4 | 7.05% |
| Shares short (prior month 12 Oct 2023) 4 | 20.72M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Sept 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -236,156.01% |
Management effectiveness
| Return on assets (ttm) | -14.19% |
| Return on equity (ttm) | -25.05% |
Income statement
| Revenue (ttm) | 48.5M |
| Revenue per share (ttm) | 0.19 |
| Quarterly revenue growth (yoy) | 733.30% |
| Gross profit (ttm) | 84.68M |
| EBITDA | -180.97M |
| Net income avi to common (ttm) | -190.1M |
| Diluted EPS (ttm) | -0.7600 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 575.43M |
| Total cash per share (mrq) | 2.29 |
| Total debt (mrq) | 64.64M |
| Total debt/equity (mrq) | 9.27% |
| Current ratio (mrq) | 16.74 |
| Book value per share (mrq) | 2.80 |
Cash flow statement
| Operating cash flow (ttm) | -163.33M |
| Levered free cash flow (ttm) | -74.96M |
© 2023 Yahoo. All rights reserved.